Mona Malekzadeh Moghani

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 7

Top Topics

Chemotherapy Induced

Cognitive Impairment

Palliative Care

Top Venues

Cancer reports (Hoboken, N.J.)

Journal of gastrointestinal cancer

Cancer medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Omid Amani, Mohammad Ali Mazaheri, Mona Malekzadeh Moghani, Fariba Zarani, Rasool Hamidi Choolabi
Chemotherapy-induced cognitive impairment in breast cancer survivors: A systematic review of studies from 2000 to 2021. Cancer reports (Hoboken, N.J.) 7 (2) (2024)
Omid Amani, Mohammad Ali Mazaheri, Mona Malekzadeh Moghani, Fariba Zarani, Rasool Hamidi Choolabi
Chemotherapy-induced cognitive impairment in breast cancer survivors: A systematic review of studies from 2000 to 2021. Cancer reports (Hoboken, N.J.) 7 (2) (2024)
Omid Amani, Mohammad Ali Mazaheri, Mona Malekzadeh Moghani, Fariba Zarani, Rasool Hamidi Choolabi
Mediating effects of rumination on insomnia in cancer survivors: Influences of cancer-related fatigue, fear of recurrence, and psychological distress. Cancer medicine 13 (18) (2024)
Omid Amani, Mohammad Ali Mazaheri, Mona Malekzadeh Moghani, Fariba Zarani, Rasool Hamidi Choolabi
Chemotherapy-induced cognitive impairment in breast cancer survivors: A systematic review of studies from 2000 to 2021. Cancer reports (Hoboken, N.J.) 7 (2) (2024)
Omid Amani, Mohammad Ali Mazaheri, Mona Malekzadeh Moghani, Fariba Zarani, Rasool Hamidi Choolabi
Chemotherapy-induced cognitive impairment in breast cancer survivors: A systematic review of studies from 2000 to 2021. Cancer reports (Hoboken, N.J.) 7 (2) (2024)
Omid Amani, Mohammad Ali Mazaheri, Mona Malekzadeh Moghani, Fariba Zarani, Rasool Hamidi Choolabi
Chemotherapy-induced cognitive impairment in breast cancer survivors: A systematic review of studies from 2000 to 2021. Cancer reports (Hoboken, N.J.) 7 (2) (2024)
Mona Malekzadeh Moghani, Sam Alahyari, Afshin Moradi, Malihe Nasiri
Pathological Predictors of Response to Neoadjuvant Treatment in Rectal Carcinoma. Journal of gastrointestinal cancer 52 (2) (2021)